Diasome seeks perspectives from clinicians, scientists, thought leaders and people living with diabetes to foster discussions about living with diabetes and to better inform our development of cutting-edge therapies.
Who with Diabetes REALLY Requires Insulin?
Hope Warshaw, MMSc, RD, CDE, BC-ADM
March 13, 2020
It’s clear from these numbers that while everyone with type 1 takes insulin, many more people with type 2 do as well. It’s also clear that the traditional classifications for diabetes are evolving.
Everyone Can Help: What Pharmacists Can Do to Help Manage Diabetes
February 28, 2020
Diabetes is one of the most common and costly chronic diseases in the country, with the Centers for Disease Control and Prevention reporting that it currently affects 30.3 million Americans. It’s important to investigate how different members of the healthcare community can help address this issue and play an active role in helping patients manage their condition.
Why I’m an Unrelenting Peer Support Advocate
Hope Warshaw, MMSc, RD, CDE, BC-ADM
February 11, 2020
We know that managing diabetes is arduous and unrelenting 24/7/365. Living life with diabetes can also be isolating, lonely and stigmatizing. Surrounding oneself with a community of people who “get it” truly matters.
James H. Gilmore
November 1, 2019
The keyboard merely serves as an icon for the technological treatment...displacing true care for the person. And it suggests a need for medical care that does more than devolve into mere data-gathering and treatment administration.
Exercise and Insulin-Dependent Diabetes
October 11, 2019
There is no doubt that exercise is good for everybody, and as people living with diabetes, we are encouraged to move daily. The only problem with that advice is that insulin is a temperamental hormone, and how effective it is can be greatly impacted by exercise.
Diabetes Mine interviews Diasome CEO, Robert Geho
September 27, 2019
Bob has a special mission as CEO at Diasome. He lives with type 1 diabetes himself, and passionately believes that his company can make injected insulin work better in the bodies of people with diabetes.
An interview with Karin Hehenberger, M.D., Ph.D., founder and CEO of Lyfebulb, about her experience with type 1 diabetes
Karin Hehenberger, M.D., Ph.D
September 13, 2019
It is so important that we can serve as the bridge between the patient community and industry. I think the industry desperately needs more patient insights. I would like to see more patients invited to sit at the table.
Parenting My Diabetes
Anna Norton, MS
August 30, 2019
The blood sugar management I had accomplished was slowly becoming less of a priority for me. Then I began to experience hypoglycemia unawareness.
Historical Gratitude and Where We Still Need to Innovate — “Heartware”
August 15, 2019
When people must self-manage a condition, they need a supporting partner, a health professional who creates connection, trust, safety and collaboration.
A Type 1 Diabetes Perspective
July 26, 2019
Even with all the information out there, there is still a massive misunderstanding about just what type 1 diabetes is and why there is such an urgent need for us to have insulin.
This Site Does Not Provide Medical Advice
The information, content, and material on the Diasome blog website are not medical advice. The Diasome blog content is intended for informational purposes only, and Diasome is not responsible for errors or omissions in the information posted to the Diasome blog. The Diasome blog content is not a substitute for professional medical advice, diagnosis and/or treatment. You should never ignore medical advice in seeking treatment because of something that you have read on the Diasome blog. Always consult with your physician or other qualified health care provider with any questions you may have regarding your personal health or healthcare related matters. You should not use the information contained on the Diasome blog to self-diagnose or self-treat any health-related condition. Diasome gives no assurance or warranty regarding the accuracy, timeliness or applicability of the Diasome blog content.